What does Immo Mediplus Bornem do?

Immo Mediplus Bornem is a property company in Bornem. Private Limited, started on 20 May 2020, 1 establishment.

What is the address of Immo Mediplus Bornem?

The registered office of Immo Mediplus Bornem is located at Hingenesteenweg(BOR) 60B, 2880 Bornem.

Is Immo Mediplus Bornem still active?

Yes. According to the CBE (2 November 2026) Immo Mediplus Bornem is active, legal situation “Normale toestand”, started on 20 May 2020.

Is Immo Mediplus Bornem registered on Peppol?

Yes, Immo Mediplus Bornem is registered on the Peppol network with ID 0208:0747520404.

What is the enterprise number of Immo Mediplus Bornem?

The enterprise number of Immo Mediplus Bornem is BE0747520404.

When was Immo Mediplus Bornem founded?

Immo Mediplus Bornem was founded on 20 May 2020.

Who are the directors of Immo Mediplus Bornem?

According to the 2025 annual accounts, the directors of Immo Mediplus Bornem are: Isabelle Boon, Frederik Schellekens.

Is Immo Mediplus Bornem a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 May 2020; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Immo Mediplus Bornem make in 2025?

Immo Mediplus Bornem posted a profit after taxes of € 47,340 in financial year 2025.

What is the revenue of Immo Mediplus Bornem?

As a small company, Immo Mediplus Bornem is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 117,880.

Immo Mediplus Bornem (Private Limited) - Bornem

Dossier Immo Mediplus Bornem, printed on 3 November 2026 from databakkes.be/en/0747520404/immo-mediplus-bornem. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 44 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Immo Mediplus Bornem from Bornem, company number BE0747520404, closed financial year 2025 with a result of € 47,340 after tax. For that financial year Immo Mediplus Bornem recorded a gross margin of € 117,880 and equity of € 30,000. Compared with financial year 2024, the result moved from € 77,931 to € 47,340. The company is profitable. The buffer shrank hard: equity is 52 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 15, 2026.

What it is worth Shrank hard

€ 30,000

▼ 52% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 47,340

▼ 39% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 74,677

▼ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 79,756 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Wage cost

€ 10,413

▲ 2% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 7,089

▼ 42% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 17 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 403,565

▼ 31% vs 2024

€ 23,499 is repaid this year. At this pace the long-term loan is gone in ≈ 17 years.

Owed to suppliers

€ 8,016

▲ € 7,095 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 13,427

▼ 5% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 16,302 Gross margin 2022: € 16,302 First fiscal year in the series	€ 42,253 Gross margin 2023: € 42,253 ▲ 159% vs 2022 (€ 16,302) Favourable step	€ 145,925 Gross margin 2024: € 145,925 ▲ 245% vs 2023 (€ 42,253) Favourable step	€ 117,880 Gross margin 2025: € 117,880 ▼ 19% vs 2024 (€ 145,925) Unfavourable step	▼ 19%
Profit after taxes	€ -21,611 Profit after taxes 2022: € -21,611 First fiscal year in the series	€ -6,862 Profit after taxes 2023: € -6,862 ▲ € 14,749 vs 2022 (€ -21,611) Favourable step	€ 77,931 Profit after taxes 2024: € 77,931 ▲ € 84,793 vs 2023 (€ -6,862) Favourable step	€ 47,340 Profit after taxes 2025: € 47,340 ▼ 39% vs 2024 (€ 77,931) Unfavourable step	▼ 39%
Equity	€ -8,653 Equity 2022: € -8,653 First fiscal year in the series	€ -15,515 Equity 2023: € -15,515 ▼ € 6,862 vs 2022 (€ -8,653) Unfavourable step	€ 62,416 Equity 2024: € 62,416 ▲ € 77,931 vs 2023 (€ -15,515) Favourable step	€ 30,000 Equity 2025: € 30,000 ▼ 52% vs 2024 (€ 62,416) Unfavourable step	▼ 52%
Total debts	€ 634,139 Total debts 2022: € 634,139 First fiscal year in the series	€ 623,191 Total debts 2023: € 623,191 ▼ 2% vs 2022 (€ 634,139) Favourable step	€ 599,373 Total debts 2024: € 599,373 ▼ 4% vs 2023 (€ 623,191) Favourable step	€ 590,430 Total debts 2025: € 590,430 ▼ 1% vs 2024 (€ 599,373) Favourable step	▼ 1%
Cash	€ 5,811 Cash 2022: € 5,811 First fiscal year in the series	€ 5,874 Cash 2023: € 5,874 ▲ 1% vs 2022 (€ 5,811) Favourable step	€ 79,227 Cash 2024: € 79,227 ▲ € 73,353 vs 2023 (€ 5,874) Favourable step	€ 74,677 Cash 2025: € 74,677 ▼ 6% vs 2024 (€ 79,227) Unfavourable step	▼ 6%
Land & buildings	€ 445,468 Land & buildings 2022: € 445,468 First fiscal year in the series	€ 431,784 Land & buildings 2023: € 431,784 ▼ 3% vs 2022 (€ 445,468) Unchanged	€ 418,100 Land & buildings 2024: € 418,100 ▼ 3% vs 2023 (€ 431,784) Unchanged	€ 404,416 Land & buildings 2025: € 404,416 ▼ 3% vs 2024 (€ 418,100) Unchanged	▼ 3%
Retained profit	€ -38,653 Retained profit 2022: € -38,653 First fiscal year in the series	€ -45,515 Retained profit 2023: € -45,515 ▼ € 6,862 vs 2022 (€ -38,653) Unfavourable step	€ 32,416 Retained profit 2024: € 32,416 ▲ € 77,931 vs 2023 (€ -45,515) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 32,416) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 79,756 Dividend 2025: € 79,756 Unchanged (€ 0) Unchanged
Bank debt	€ 626,507 Bank debt 2022: € 626,507 First fiscal year in the series	€ 604,021 Bank debt 2023: € 604,021 ▼ 4% vs 2022 (€ 626,507) Favourable step	€ 581,221 Bank debt 2024: € 581,221 ▼ 4% vs 2023 (€ 604,021) Favourable step	€ 403,565 Bank debt 2025: € 403,565 ▼ 31% vs 2024 (€ 581,221) Favourable step	▼ 31%
Balance sheet total	€ 625,485 Balance sheet total 2022: € 625,485 First fiscal year in the series	€ 607,675 Balance sheet total 2023: € 607,675 ▼ 3% vs 2022 (€ 625,485) Unchanged	€ 661,789 Balance sheet total 2024: € 661,789 ▲ 9% vs 2023 (€ 607,675) Unchanged	€ 620,430 Balance sheet total 2025: € 620,430 ▼ 6% vs 2024 (€ 661,789) Unchanged	▼ 6%

Key figures of Immo Mediplus Bornem, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Immo Mediplus Bornem?

What happened at Immo Mediplus Bornem in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 15, 2026 New annual accounts for financial year 2025: profit of € 47,340 (▼ 39% vs 2024). Source: NBB ↗
May 20, 2020 New establishment in Bornem. KBO
May 20, 2020 Start of the company according to the CBE. KBO
2020 Isabelle Boon became a director. NBB
2020 Frederik Schellekens became a director. NBB

In short

From € 21,611 loss in 2022 to € 47,340 profit in 2025.

Paid € 24,114 in corporate taxes since 2022.

Best year ever: 2024, with € 77,931 profit.

Paid out € 79,756 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Isabelle Boon Frederik Schellekens

Dr. Boon Isabelle

F&I Projects

Immo Mediplus Bornem

Behind Immo Mediplus Bornem are Isabelle Boon and Frederik Schellekens. The same people are also behind F&I Projects. Isabelle Boon is also behind Dr. Boon Isabelle.

Directors

According to the 2025 annual accounts

Isabelle Boon

Director

Also active at: Dr. Boon Isabelle, F&I Projects

since 2020

Frederik Schellekens

Director

Also active at: F&I Projects

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Hingenesteenweg(BOR) 60B

2880 Bornem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0747.520.404
VAT number: BE 0747.520.404
Registered office: Hingenesteenweg(BOR) 60B, 2880 Bornem
Names & denominations: Immo Mediplus Bornem
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 May 2020
Peppol: Active · Active since 27 Nov 2025
Activities · NACE: Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

View on CBE Public ↗ Annual accounts (NBB) ↗